ADAMTS5
ADAMTS5 (ADAM metallopeptidase with thrombospondin type 1 motif 5, also known as ADMP-2 or ADAMTS11) is a secreted metalloproteinase that degrades extracellular matrix proteoglycans. It is best known as aggrecanase-2, an enzyme that cleaves aggrecan in cartilage. Browse Assay Genie's current range of ADAMTS5 research reagents below, or read on for the biology behind the target.
ADAMTS5 is a metalloproteinase that contributes to connective tissue organisation, development, inflammation and cell migration. It is an extracellular matrix (ECM) degrading enzyme with proteolytic activity toward the hyalectan group of chondroitin sulfate proteoglycans, including aggrecan (ACAN), versican (VCAN), brevican (BCAN) and neurocan (NCAN). Cleavage within the hyalectans occurs at Glu-Xaa recognition motifs.
The ADAMTS5 gene encodes a member of the ADAMTS family, whose members share a propeptide region, a metalloproteinase domain, a disintegrin-like domain and a thrombospondin type 1 (TS) motif. Family members differ in the number of C-terminal TS motifs, and ADAMTS5 contains two. The encoded preproprotein is proteolytically processed to generate the mature enzyme, which is found in the extracellular space and extracellular matrix. The mouse ortholog is Adamts5.
Beyond cartilage, ADAMTS5 has roles in development. It participates in embryonic limb and cardiac morphogenesis, and in skeletal muscle development through its VCAN remodelling activity: it cleaves VCAN in the pericellular matrix around myoblasts, which facilitates myoblast contact and fusion needed for muscle development and regeneration. It also participates in the development of brown adipose tissue and the browning of white adipose tissue, and is important for T-lymphocyte migration from draining lymph nodes following viral infection. Because it cleaves aggrecan, a major proteoglycan of cartilage, it may mediate cartilage destruction in osteoarthritis. The previous name, aggrecanase-2, reflects this activity.
ADAMTS5 cleaves aggrecan, a major cartilage proteoglycan, and may mediate cartilage destruction in osteoarthritis.
As an ECM-degrading enzyme acting on hyalectans such as ACAN, VCAN, BCAN and NCAN, it is a model for proteoglycan turnover.
ADAMTS5 cleaves VCAN around myoblasts, facilitating the myoblast contact and fusion required for skeletal muscle development and regeneration.
The enzyme participates in brown adipose tissue development and white adipose browning, and supports T-lymphocyte migration from lymph nodes after viral infection.
ADAMTS5 is a secreted metalloproteinase that degrades extracellular matrix proteoglycans of the hyalectan group, including aggrecan, versican, brevican and neurocan, cleaving at Glu-Xaa motifs. It contributes to connective tissue organisation, development, inflammation and cell migration.
ADAMTS5 is also called ADMP-2 and ADAMTS11, and was previously named aggrecanase-2. The HGNC name is ADAM metallopeptidase with thrombospondin type 1 motif 5. The protein is synthesised as a preproprotein that is proteolytically processed to give the mature enzyme.
NCBI Gene notes that ADAMTS5 may mediate cartilage destruction in osteoarthritis through aggrecan cleavage. A mouse ortholog, Adamts5, is recorded, and the mouse gene is also linked to limb and cardiac development. Check the datasheet of any product for its validated reactivity.
Other ADAMTS family metalloproteinases, including the related aggrecanase ADAMTS4, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9UNA0; product specifications from Assay Genie datasheets.